4Bellomo R, Mehta R. Acute renal replacement in the intensive care unit: now and tomorrow. New Horiz ,1995 ,3 :760 - 767.
5Silvester W, Bellomo R, Ronco C. Continuous versus intermittent renal replacement therapy in the critically ill. In:C. Ronco, R. Bellomo, eds. Critical Care Nephrology. Dordrecht: Kluwer Academic Publishers, 1998,1225 - 1238.
6Schetz M, Ferdinande P, Van der Berghe G, et al. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med, 1995,21 : 169 - 176.
7Van Bommel EF, Hesse CJ, Jutte NH, et al. Cytokine kinetics(TNF-alpha, IL-1 beta, IL-6) during continuous hemofiltration:a laboratory and clinical study. Contrib Nephrol, 1995,116:62 - 75.
8Ronco C, Tetta C, Lupi A, et al. Removal for plateletactivating factor in experimental continuous arteriovenous hemofltration. Crit Care Med, 1995,23:99 - 107.
9Cole L, Bellomo R, Journois D,et al. Tipping p: High-volume haemofiltration in human septic shock. Intensive Care Med, 2001,27(6):978 -986.
10Bellomo R, Boyce N. Continuous veno-venous hemofiltration compared with conventional dialysis in critically ill patients with acute renal failure. ASAIO J, 1993,39:794.
